Experimentally-induced mutations in the C 3 HC 4 RING ®nger domain of the Bmi-1 oncoprotein block its ability to induce lymphomas in mice. In this report, the role of the Bmi-1 RING ®nger in mediating protein-protein interactions is examined using the yeast two-hybrid system. Bmi-1 interacts directly with the RING ®nger protein dinG/RING1B. Heterodimerization of the two proteins requires the intact RING ®nger structures of both Bmi-1 and dinG. Although the RING ®nger domains are necessary for dimerization, they are not sucient for this process as residues outside the C 3 HC 4 motif are also required. Thus, binding speci®city may be partly conferred by residues outside the RING motif. Both Bmi-1 and dinG interact with the Polyhomeotic protein MPh2 through binding domains apart from the RING ®nger. The data suggest a model whereby Bmi-1, dinG, and MPh2 form a stable heterotrimeric complex in which each protein contributes to the binding of the others.
Introduction
The bmi-1 oncogene was initially identi®ed as a common locus of retroviral integration in lymphomas arising in Moloney murine leukemia virus-infected E mmyc transgenic mice suggesting that it cooperates with myc in lymphomagenesis (Haupt et al., 1991; van Louhizen et al., 1991a) . A role for bmi-1 in the development of some lymphomas has been strengthened by the ®ndings that transgenic mice that overexpress bmi-1 are predisposed to lymphomas and that bmi-1 is overexpressed in naturally occurring lymphomas in feline leukemia virus-infected domestic cats (Haupt et al., 1993; Levy et al., 1993; Alkema et al., 1997b) . To date, aberrant expression of bmi-1 has not been reported in human malignancies; however, a close homolog of bmi-1, mel18, is expressed at high levels in human melanoma cell lines (Tagawa et al., 1990) . Human bmi-1 cDNA has been cloned and the gene mapped to chromosomal locus 10p13, facilitating the analysis of human malignancies for alterations in bmi-1 (Alkema et al., 1993) .
Bmi-1 is homologous to two Drosophila RING ®nger proteins, Posterior Sex Combs (Psc) and Suppressor two of zeste (Su(z)2), members of the Polycomb group (PcG) of proteins (Brunk et al., 1991; van Lohuizen et al., 1991b) . PcG proteins maintain heritable repression of homeotic gene expression in Drosophila, and mutations of PcG genes result in the loss of the normal pattern of body segmentation (reviewed in Epstein, 1992) . The PcG proteins assemble as large multimeric complexes that may repress genes by promoting the formation of heterochromatin (reviewed in Singh, 1994) . Recent evidence indicates that Bmi-1 forms a multimeric protein complex with at least two mammalian homologs of PcG proteins, Polycomb (Pc) and, Polyhomeotic (Ph), suggesting that some of the fundamental properties of PcG proteins are conserved from¯ies to mammals (Alkema et al., 1997a; Gunster et al., 1997; Satijn et al., 1997) . Furthermore, transgenic mice nullizygous for bmi-1 and overexpressing bmi-1 exhibit homeotic skeletal transformations, thus providing evidence that the function of PcG genes in pattern formation is also conserved through evolution (van der Lugt et al., 1994; Alkema et al., 1995) .
Several ®ndings indicate that the oncogenic properties of Bmi-1 are dependent on a distinct structural domain. Deletion of the RING ®nger abolishes the ability of Bmi-1 to transform cultured ®broblasts (Cohen et al., 1996) . Further, mutations in bmi-1 that aect conserved residues within the RING ®nger block the gene's ability to induce lymphomas in transgenic mice (Alkema et al., 1997b) . These mutations have little eect on the induction of axial skeletal anomalies mediated by Bmi-1. In contrast, the central helix-turnhelix motif of Bmi-1 appears to be essential for transcriptional suppression and for the induction of skeletal anomalies in transgenic mice (Cohen et al., 1996; Alkema et al., 1997a,b) .
The RING ®nger motif is a cysteine-rich zincbinding domain ®rst described by Freemont and colleagues (Freemont et al., 1991) . The RING ®nger is now well recognized as a structural component of a group of functionally diverse proteins. RING ®nger family members have been reported in yeast, plants, invertebrates and mammals as well as in a large number of viruses. Furthermore, within a given organism, RING ®nger proteins subserve numerous functions ranging from DNA damage repair to peroxisomal assembly (reviewed in Saurin et al., 1996) . Structural diversity also exists within the RING ®nger motif itself as indicated by variability within the concensus sequence: CX 2 CX (9 ± 39) CX (1 ± 3) HX (2 ± 3) CX 2 CX (4 ± 48) CX 2 C (C 3 HC 4 ). Nevertheless, magnetic resonance spectroscopy data derived from the RING ®nger domains of equine herpes virus gene 63 peptide, promyelocytic leukemia protein PML, and the breast cancer susceptibility protein BRCA1 indicate that unrelated RING ®ngers do share a similar basic topology (Barlow et al., 1994; Borden et al., 1995; Bienstock et al., 1996) . Speci®cally, two Zn 2+ atoms are contained within the structure, one bound to the ®rst and third pairs of metal binding ligands and a second bound to the second and fourth pair of ligands. Zn 2+ binding results in a tetrahedrally coordinated`crossbrace' that orders the domain into a hydrophobic core with a positively charged surface. It has been proposed that the RING ®nger serves as a DNA binding domain akin to the zinc ®nger. Alternatively, the RING ®nger may mediate protein-protein interactions. To date, there is evidence that the RING ®nger domain of human BRCA1 and yeast Ste5p are essential for speci®c protein interactions but there has been no de®nitive demonstration of speci®c DNA-RING ®nger binding (Wu et al., 1996; Inouye et al., 1997) .
Based on the observations that the Bmi-1 RING ®nger is essential for neoplastic transformation (Cohen et al., 1996; Alkema et al., 1997b) and that it may mediate protein interactions, we employed a yeast twohybrid selection to identify proteins that interact with the RING ®nger-containing amino-terminal portion of Bmi-1. The murine dinG/RING1B gene was isolated as a Bmi-1 interacting partner. Interestingly, dinG is also a RING ®nger protein whose RING ®nger domain shares near complete sequence identity with the protein family namesake, RING1 (Lovering et al., 1993) . RING1 proteins have recently been shown to interact with other mammalian PcG proteins, Pc1, Pc2 and M33 Schoorlemmer et al., 1997) , none of which bear structural similarities to Bmi-1.
To further characterize the Bmi-1-dinG complex, a second two-hybrid selection was undertaken to identify dinG interacting proteins. We found that the mouse homolog of the human Polyhomeotic protein, HPh2, interacts with dinG. Notably, previous studies have shown that Polyhomeotic proteins associate with Bmi-1 (Alkema et al., 1997a; Gunster et al., 1997) . Our data further suggest that Bmi-1, dinG, and MPh2 associate to form a stable ternary complex in which each protein contributes to the binding of the others. The ®ndings reinforce the concept of a mammalian PcG protein assembly that contains the Bmi-1 oncoprotein. They further provide insights into the role of the RING ®nger in mediating protein-protein interactions.
Results

Bmi-1 interacts with dinG in the yeast two-hybrid system
The Bmi-1 protein is composed of an amino terminal RING ®nger domain, a central helix-turn-helix-turnhelix-turn domain (HTHTHT), and a carboxy terminus containing a putative PEST sequence (van Lohuizen et al., 1991a; Haupt et al., 1991) . Mouse bmi-1 encoding the ®rst 167 amino acids was placed in the yeast expression vector pGBT9 to produce a truncated Bmi-1 protein fused to the yeast Gal4 DNA binding domain (BDBT 167 . Restriction endonuclease analysis of the rescued plasmid DNA from those colonies indicated that eight of the nine plasmids contained identical 1.1 kb cDNA fragments. One cDNA fragment was 0.7 kb in length and was later found to contain the 5' portion of the larger fragments. Thus, the results of the ®rst selection indicated an interaction between Bmi-1 and the product of a single gene.
The speci®city of the two-hybrid interaction revealed in this selection was con®rmed by testing the plasmid containing the 1.1 kb cDNA insert with pLAM5' encoding a Gal4BD-lamin fusion protein. Speci®city was further veri®ed in yeast strain PJ69-4A in which the Gal4 responsive elements are located within dierent gene promoters. Finally, chimeric proteins were generated in which the Gal4 BD and Gal4 AD were swapped. The results of these experiments demonstrate that the two-hybrid interaction between Bmi-1 and the product of the 1.1 kb cDNA is speci®c, is not dependent upon the fusion of either protein to a speci®c Gal4 protein domain, and is not dependent upon a particular Gal4 responsive promoter ( Figure 1 ). To address the possibility that the interaction may be an artifact resulting from truncation of the Bmi-1 protein, full-length Bmi-1 fused to the Gal4 BD was tested and was found to interact with the product of the 1.1 kb cDNA.
The sequence of the 1.1 kb cDNA isolated by twohybrid selection was determined and was found to match that of human dinG cDNA (Accession #Y10571). By comparison to the sequence of human dinG, the cDNA fragment was shown to begin at the second codon of the dinG coding sequence. The 5' untranslated region of mouse dinG was isolated by rapid ampli®cation of cDNA ends (RACE) (Frohman, Figure 1 Yeast two-hybrid interaction of the dinG protein with the amino-terminal, RING ®nger containing fragment of Bmi-1. dinG was fused to the Gal4 DNA binding domain (Gal4BD) or to the Gal4 transactivation domain (Gal4AD) and tested for its ability to interact with Bmi-1 truncated at position 167 (Bmi-1/ T 167 ), a lamin fusion protein, or Gal4 domains alone. Assays were performed in two genotypically distinct yeast strains that contain dierent reporter genes to further verify the speci®city of the interaction. Two-hybrid interaction was scored as positive (+) if yeast cells exhibited growth on histidine de®cient synthetic medium containing 10 mM 3-aminotriazole (GAL1-HIS3) or adenine de®cient medium (GAL2-ADE2), or if b-galactosidase activity was detected by ®lter lift assay (Gal1-lacZ) 1993). The 5' UTR is highly GC-rich, contains a Kozak translation initiation sequence (Kozak, 1987) , and no other potential initiation codons. The predicted human and murine gene products are 96% identical indicating that the 1.1 kb cDNA contained the mouse homolog of the dinG gene. Subsequently, the sequence was found to be identical to the recently described mouse RING1B cDNA (Accession #Y12783 and Y12880) (Schoorlemmer et al., 1997) . We have elected to maintain the designation dinG.
The mouse dinG cDNA sequence is predicted to encode a protein of at least 344 amino acids with a M r of 38 300. The amino terminal portion of the protein contains a C-X 2 -C-X 12 -C-X-H-X 2 -C-X 2 -C-X 11 -C-X 2 -C RING ®nger motif that shares exact residue spacing and 95% identity with the RING ®nger motif of human RING1 (Lovering et al., 1993) . As described by Schoorlemmer et al. (1997) , additional regions of signi®cant homology exist within dinG/RING1B and RING1 at the carboxy termini. With the exception of the RING ®nger domain, however, RING1 is the only protein in the database that shares signi®cant homology with dinG/RING1B.
An intact Bmi-1 RING ®nger is necessary but not sucient for dinG binding
To determine the role of the Bmi-1 RING ®nger to dinG binding, speci®c mutations were introduced into the RING ®nger domain of the dinG-binding aminoterminal fragment of Bmi-1, BT 167 . Proteins were expressed as Gal4 BD chimeras and tested for their ability to interact with Gal4 AD-dinG in the twohybrid system (Figure 2 ). Deletion of residues 1 ± 44 of Bmi-1 eliminates six of the eight conserved cysteine and histidine residues and is predicted to disrupt the normal RING structure. This deletion mutant, BT 167 ND44, does not interact with dinG, a result that is consistent with the hypothesis that the RING ®nger of Bmi-1 is required for dinG binding. To more precisely address this hypothesis, conserved cysteine residues within the RING ®nger were mutated to phenylalanine. The BT 167 C21F protein contains a mutation in the ®rst cluster of zinc ligands while BT 167 C53F contains a mutation in the second cluster. Based on models of the PML protein structure, both C?F mutations will disturb the tetrahedral coordination of Zn 2+ within the RING ®nger scaold (Borden et al., 1995) . When expressed in the two-hybrid system, neither mutant protein interacts with dinG. On the basis of these experiments, we conclude that an ordered Bmi-1 RING ®nger structure is necessary for a stable Bmi-1-dinG interaction.
The dinG binding interface of Bmi-1 was further mapped to evaluate the possibility that the RING ®nger motif alone is responsible for protein binding. Truncation of the protein at residue 109 still produces a robust two-hybrid signal, however truncation at residue 69 completely eliminates reporter gene activity. The C 3 HC 4 RING motif encompasses amino acids 18 ± 56 suggesting that amino acids that extend beyond the conserved C and H residues make important contributions to a functional protein binding surface. Thus, while the structural integrity of the Bmi-1 RING ®nger is required for dinG binding, the C 3 HC 4 motif alone is insucient for binding.
The RING ®nger of dinG is required but is insucient for binding to Bmi-1
The observation that the RING ®nger of Bmi-1 is required for binding to another RING ®nger protein, dinG, raises the possiblity that RING ®nger domains are responsible for heterodimerization. To further investigate this, the RING ®nger-containing aminoterminal portion of dinG was tested for its ability to form a stable complex with Bmi-1. dinG was truncated at amino acid 163 to create the Gal4 fusion protein BDdinGT 163 . This chimeric molecule strongly interacts with truncated Bmi-1 (BT 167 ) in the two-hybrid system. A carboxy-terminal fragment of dinG encompassing residues 157 ± 344 generated no signal when similarly tested with Bmi-1. Point mutations predicted to disupt the RING ®nger structure were then introduced into dinG. A C51F C54F double mutant was produced in which the second Zn 2+ binding site is altered. This molecule, dinG(CF) 2 , does not interact with truncated Bmi-1 in contrast to both wild-type dinG and dinGT 163 which interact strongly under the same assay conditions (Figure 3) . These results suggest that ordered RING ®nger structures of both Bmi-1 and dinG are required for protein heterodimerization.
Additional mapping of the Bmi-1 binding region of dinG was performed to determine whether residues outside the dinG RING ®nger participate in protein dimerization. The C 3 HC 4 motif spans residues 51 ± 89 of dinG. A dinG molecule containing the entire RING ®nger and truncated at residue 110 fails to interact with Bmi-1 in the two-hybrid system ( Figure  3) . Therefore, in order to heterodimerize, both Bmi-1 and dinG appear to require amino acids situated more than 15 ± 20 residues carboxy-terminal to the C 3 HC 4 motifs. To begin to develop a model of Bmi-1/dinG function, a yeast two-hybrid selection was initiated for dinG interacting protein (`Dips'). The cDNA sequence encoding dinG isolated in the initial two-hybrid selection (aa 1 ± 344) was fused to the Gal4 DNA binding domain and used as`bait'. Selection was performed with the same mouse 11 day embryo cDNA library, however yeast strain PJ69-4A was used as the host. An initial selection of 3610 Eight of the nine library isolates contained identical 1.0 kb cDNA inserts. The remaining plasmid contained a cDNA molecule that will be described elsewhere. Sequence analysis of one of the 1.0 kb cDNA clones showed near identity to the human HPh2 gene, a homolog of the Drosophila PcG gene Polyhomeotic . The 1.0 kb cDNA two-hybrid clone encodes a truncated protein that lacks the aminoterminus corresponding to residues 1 ± 136 of the human homolog HPh2. We have designated the mouse gene MPh2. At least one other human Polyhomeotic gene (HPh1) and its mouse homolog (Rae28/MPh1) have been previously identi®ed. HPh1 and Rae28/MPh1, like other members of the gene family, encode conserved Polyhomeotic Homology Domains I and II (Alkema et al., 1997a; . Perhaps more important, both human Polyhomeotic proteins as well as mouse MPh1 have recently been shown to interact with Bmi-1 (Alkema et al., 1997a; Gunster et al., 1997) .
Bmi-1, dinG and MPh2 form a stable trimeric complex
Taken together, our ®ndings that Bmi-1 associates with dinG and that dinG interacts with MPh2, suggests that the three proteins may form a stable complex. An alternative model is that the proteins share overlapping binding sites that permit the formation of heterodimers but not ternary complexes. To investigate these alternative models, we ®rst mapped the MPh2 binding site of dinG. Gal4 BD fusion proteins were expressed containing dinG residues 1 ± 163 (dinGT 163 ), 109 ± 344 (dinGND108) or 157 ± 344 (dinG-C) and tested for their ability to interact with MPh2 in the two-hybrid system (Figure 4) . The results indicate that MPh2 binds to the mid-to carboxy-terminal portion of dinG. In contrast, as shown in Figure 2 , Bmi-1 binds the aminoterminal portion of dinG.
We then mapped the MPh2 binding site of Bmi-1. The amino-terminal Bmi-1 fragment BT 167 did not interact with MPh2, however, a strong two-hybrid interaction occurred between a Bmi-1 fragment spanning residues 110 ± 225 (BT 225 ND109) and MPh2 (Figure 4) . Thus, MPh2 interacts with the central HTHTHT portion of Bmi-1, a region that is distinct from the amino-terminal dinG binding site. We therefore propose a model for a heterotrimeric complex in which Bmi-1 and dinG interact with one another through RING ®nger amino-terminal domains while MPh2 simultaneously binds Bmi-1 and dinG at positions that lie outside the amino-terminal half of the molecules ( Figure 5 ).
While the protein binding regions of the three molecules suggest that a trimeric complex may exist, we wished to further test this possibility. The complete bmi-1 coding sequence and the 1.0 kb MPh2 cDNA clone were expressed in the two-hybrid system as Gal4 fusion proteins. The ability of native full-length dinG to enhance the two-hybrid interaction of Bmi-1 FL and MPh2 was then examined by a quantitative bgalactosidase assay. In this assay, expression of the lacZ gene is regulated by a Gal4p responsive element; thus b-galactosidase activity provides an estimate of the strength of two-hybrid protein interactions. Co-transformation of yeast cells containing the bmi-1 and MPh2 two-hybrid plasmid molecules with the yeast expression vector pBEVY-dinG was shown to boost b-galactosidase activity relative to cells containing the two-hybrid plasmids and the pBEVY-U vector control. Similar ®ndings were observed when native full length bmi-1 was expressed in conjuction with dinG and MPh1 two-hybrid plasmids (Table 1) . Ura 7 yeast colonies that lost the pBEVY-dinG expression vector were screened and Figure 3 Mapping of the Bmi-1 binding domains of dinG. Fragments of dinG were expressed as Gal4 DNA binding domain chimeras and tested for their ability to interact with truncated Bmi-1 (Bmi-1/T 167 ) fused to the Gal4 transactivation domain. Assays were performed as described in Figure 2 . dinG FL indicates full-length dinG protein. Numeric subscripts indicate the residue at which dinG fragments were truncated. dinG-C term encompasses carboxy-terminal residues 157 ± 344. dinG(CF) 2 contains C?F substitutions at residues 51 and 54 and are indicated by .. Black boxes represent the location of the RING ®nger domain Figure 4 Mapping of the MPh2 binding domains of dinG (above) and Bmi-1 (below). Fragments of dinG and Bmi-1 were expressed as Gal4 DNA binding domain chimeras and tested for their ability to interact with MPh2 fused to the Gal4 transactivation domain. Assays were performed as described in Figure 2 . Subscripts and symbols are as described in Figures 2  and 3 re-tested. The b-galactosidease activity of these Ura 7 yeast isolates that no longer express dinG returned to the baseline originally observed for colonies containing the bmi-1 and MPh2 two-hybrid plasmids and the control vector pBEVY-U (data not shown). This result indicates that an increase in b-galactosidase activity was dependent on expression of the dinG protein. The data support the model for a ternary complex in which Bmi-1/MPh2 interaction is stabilized by dinG.
Discussion
The PcG genes were originally described and characterized in Drosophila. A large body of evidence indicates that the¯y PcG proteins serve a crucial role in development by maintaining normal patterns of homeotic gene repression (reviewed in Epstein, 1992 and in Singh, 1994) . PcG proteins are detected in a large complex with a M r of 2 ± 5610 6 and co-localize to speci®c sites on polytene chromosomes (Franke et al., 1992) . These data, in conjunction with genetic analyses indicating that PcG genes act synergistically, have led to the proposal that PcG proteins assemble as large heteromeric complexes at speci®c gene loci. Several Drosophila PcG proteins have been demonstrated to possess transcriptional repressor activity when targeted to reporter genes by LexA or Gal4 fusions (Bunker and Kingston, 1994; Muller, 1995) . The ability of PcG proteins to silence gene expression may be due to the promotion of heterochromatin formation by the PcG complex (reviewed in Singh, 1994) .
Mammalian PcG genes have been identi®ed in mouse and in man and include bmi-1 and mel18, homologs of Drosophila Psc, and Su(2)Z; M33, HPc1, and HPc2, homologs of Drosophila Pc; Rae28/MPh1/ HPh1 and HPh2, homologs of Drosophila Ph; and eed, a Drosophila esc homolog (Tagawa et al., 1990; Haupt et al., 1991; van Lohuizen et al., 1991a,b; Pearce et al., 1992; Satijn et al., 1997; Alkema et al., 1997a; Gunster et al., 1997; Denisenko and Bomsztyk, 1997) . The conserved function of these genes has been demonstrated by the homeotic transformation observed in bmi-1 and mel18 transgenic mice as well as by the ability of the mouse M33 gene to complement Pc mutations in Drosophila (van der Lugt et al., 1994; Alkema et al., 1995; Muller et al., 1995; Akasaka et al., 1996) . Like their Drosophila counterparts, mammalian PcG proteins appear to associate as a heteromeric complex. Thus, Rae28/MPh1/HPh1 and HPh2 were recently identi®ed as mammalian PcG genes whose products directly interact with Bmi-1 while HPc2 coimmunoprecipitates with Bmi-1 and HPh1 (Alkema et al., 1997a; Gunster et al., 1997; Satijn et al., 1997) .
Protein-protein interactions among the PcG proteins and their mammalian counterparts may be mediated, in part, by the RING ®nger. Mutational analysis of Bmi-1 indicates that an intact and properly ordered RING ®nger is required for Bmi-1/dinG binding (Figure 2 ). While the super®cial similarity between the C 3 HC 4 motif of the RING ®nger and the C 4 motif of a classic zinc ®nger suggest that the RING ®nger may mediate sequence-speci®c DNA binding, emerging data implicate the RING ®nger in protein dimerization. The Ste5 protein of budding yeast, a`scaold' protein that links signaling molecules of the pheromone response pathway, contains a RING-H2 domain (C 3 HHC 3 ). Mutations of the metal binding ligands block the ability of Ste5p to bind Ste4p but do not disturb the general structure or stablity of the protein (Inouye et al., 1997) . Furthermore, the product of the familial breast cancer susceptibility gene BRCA1 contains a RING ®nger that is required for the interaction with another RING ®nger protein, BARD1. Naturally occurring mutations of the BRCA1 RING ®nger that are associated with familial breast cancer disrupt the interaction between BRCA1 and BARD1 (Wu et al., 1996) .
In addition to its apparent function at the molecular level in mediating protein dimerization, the RING Figure 5 A proposed model for a heterotrimeric protein complex composed of Bmi-1, dinG, and MPh2. Bmi-1 and dinG interact through their respective RING ®nger domains as well as adjacent residues. MPh2 associates with the central HTHTHT region of Bmi-1 as well as with the mid-to carboxy-terminal portion of dinG Bmi-1 protein-protein interactions CS Hemenway et al ®nger domain of Bmi-1 is required for its oncogenic properties (Cohen et al., 1996; Alkema et al., 1997a,b) . Notably, RING ®nger mutations of bmi-1 do not aect the protein's ability to induce homeotic skeletal transformation in transgenic mice. In this process, the central HTHTHT domain of Bmi-1 appears essential (Alkema et al, 1997a) . dinG, a protein that binds Bmi-1 in a RING ®nger-dependent manner, may thus serve an important role in Bmi-1-induced lymphomas. The function of dinG is not immediately apparent from sequence analysis, but it has recently been shown to interact with the mouse PcG protein, M33. The dinG/ RING1B homolog, RING1, has been shown to repress reporter gene activity when targeted by fusion to LexA or Gal4, but the in vivo function of RING1 remains elusive Schoorlemmer et al., 1997) .
We ®nd that a Bmi-1-dinG heterodimer binds the PcG protein, MPh2 (Figure 4 ; Table 1 ). Others have shown co-localization of Bmi-1, RING1 and HPh1 in human SW480 cells and of Bmi-1, RING1, and M33 in U2-OS cells Schoorlemmer et al., 1997) . Our results provide some insights into the nature of the molecular interactions among the PcG proteins. Our data indicate that Bmi-1 and dinG molecules both contain discrete binding sites for MPh2 and are capable of binding MPh2 either alone or as a Bmi-1-dinG heterodimer (Figures 4 and 5 ). Moreover, when tested in the two-hybrid system, the interaction of Bmi-1 or dinG with MPh2 is strengthened by the coexpression of dinG or bmi-1, respectively (Table 1) . These results indicate that one function of dinG is to contribute to the formation of a stable mammalian PcG complex. While there is no known Drosophila homolog of dinG, it seems likely that dinG is a functional member of the PcG family of proteins.
Our results add to the accumulating evidence that the RING ®nger motif functions, at least in part, as a protein dimerization domain. BRCA1/BARD1 and Ste5p/Ste4p serve as additional examples in which the RING ®nger is required for protein-protein interactions (Wu et al., 1996; Inouye et al., 1997) . Interestingly, BRCA1 and BARD1, like Bmi-1 and dinG, both contain RING ®ngers. The present ®ndings with Bmi-1 and dinG suggest that the RING ®nger of each binding partner is essential. Our experiments do not address whether or not the RING ®nger domains make direct reciprocal contacts. Amino acids situated apart from the C 3 HC 4 sequence are also essential for protein binding and it may be these residues that are contacted by the interacting RING ®nger domain. The Ste4 protein does not contain a RING ®nger indicating that at least some RING ®nger binding interfaces are not composed of a second RING ®nger domain.
In sum, our data provide insights into the nature of a putative PcG complex that contains the Bmi-1 oncoprotein. We ®nd that Bmi-1 interacts with dinG/ RING1B, a RING ®nger protein that is a homolog of human RING1 (Lovering et al., 1993; Schoorlemmer et al., 1997) . The RING ®nger domain of Bmi-1 is necessary but not sucient for dimerization with dinG. Similarly, the dinG RING ®nger is required for Bmi-1 heterodimerization but alone is insucient to promote protein-protein interaction. These data suggest that the RING ®nger provides a scaold for a protein binding interface whose binding speci®city is partly determined by residues that lie outside the C 3 HC 4 motif. We also ®nd that both Bmi-1 and dinG bind the mouse Polyhomeotic protein, MPh2. The protein binding sites Bmi-1 and dinG are positioned such that Bmi-1, dinG and MPh2 may associate to form a stabilized heterotrimeric PcG protein complex.
Materials and methods
Plasmid construction
Plasmids were generated by inserting PCR-synthesized fragments of the mouse bmi-1 and dinG genes into yeast expression vectors. Two-hybrid expression vectors included pGBT9 (Gal4 DNA binding domain), PGAD10 and pGAD424 (Gal4 DNA activation domain). Native proteins were expressed from the 2 m high copy yeast plasmid pBEVY-U (Gift of Charles Miller, Tulane University). PCR site-directed mutagenesis was performed as described (Cormack, 1995) . PCR generated fragments were sequenced for veri®cation. Oligonucleotide sequences used for PCR will be provided upon request. RACE reactions were performed using a mouse 11 day embryo cDNA library (Clontech) according to the manufacturer's protocol. RACE products were cloned directly into the pGEM-T vector (Promega).
Yeast two-hybrid system
Yeast cells and plasmids were manipulated according to standard protocols (Rose et al., 1990) . Yeast two-hybrid system selections were performed using a mouse 11 day embryo cDNA library cloned into the two-hybrid expression vector pGAD10 (Clontech). In the ®rst selection, yeast strain Y190 was used as a host and contained a truncated bmi-1 gene cloned into pGBT9 as bait'. Cells were transformed in LiOAc and incubated on synthetic medium containing 10 mM 3-aminotriazole and lacking histidine, leucine and tryptophan. His + colonies were then tested for b-galactosidase activity by a ®lter-lift assay (Durfee et al., 1993) . In the second selection, yeast strain PJ69-4A containing a dinG`bait' plasmid, was transformed in LiOAc and incubated on synthetic medium lacking adenine, leucine, and tryptophan. Ade + colonies were then tested for histidine prototrophy on synthetic medium (James et al., 1996) .
Speci®c analyses of protein-protein interactions were performed by two-hybrid assay in yeast strain PJ69-4A. A minimum of three Leu + Trp + transformants were selected and tested for adenine auxotrophy. Due to the minimal basal expression of the GAL2-ADE2 reporter gene in strain PJ69-4A, it was possible to score the two-hybrid protein interaction as`positive' or`negative' based on growth on synthetic medium lacking adenine. For each experiment, yeast cells transformed with the`bait' plasmid and an empty Gal4AD plasmid (pGAD424) were tested in parallel as a negative controls. Quantitative b-galactosidase assays were performed in strain Y190. Cells were grown overnight in synthetic selective media containing dextrose. b-galactosidase activity was measured as described (Cardenas et al., 1994) .
